Quarterly report pursuant to Section 13 or 15(d)

Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details Textual)

v3.3.0.814
Note 1 - Basis of Presentation and Summary of Significant Accounting Policies (Details Textual) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2015
Jun. 30, 2015
Chemo Centryx, Inc. [Member]    
Available-for-sale Securities, Amortized Cost Basis   $ 29,500
Available-for-sale Securities, Amortized Cost Basis $ 29,500 33,600
Inventory Valuation Reserves 24,000 24,000
Available-for-sale Securities 38,400 56,400
Available-for-sale Securities, Gross Unrealized Gain (Loss) (3,900)  
Inventory, Net $ 58,967 $ 49,577